Skip to main content

Table 1 VHL mutant constructs used in this study

From: Differences in regulation of tight junctions and cell morphology between VHL mutations from disease subtypes

  

Clinical phenotype (risk of tumor type)

 

Mutant VHL

Subtype

Pheo

Hemangio

RCC

References

del 114–178

1

-

++

++

[11, 53]

RC161/2QW

1

   

[53]

S65W

1

   

[29, 58, 59]

N78S

1

   

[28, 29]

L158P

1

   

[29]

L188Q

1

   

[29]a

Y98H

2A

++

++

-

[29, 60, 61]

Y112H

2A

   

[28, 29, 62]

Y98N

2B

++

++

++

[4, 63]a

Y112N

2B

   

[63]

R167Q

2B

   

[29, 58, 64, 65]

R167W

2B

   

[28, 29, 58, 64, 65]

V84L

2C

++

-

-

[66]a

L188V

2C

   

[28, 61, 67]

  1. Pheo, pheochromocytoma; hemangio, hemangioblastoma; RCC, renal cell carcinoma
  2. a subtype designation based on a small family